John R Stuelpnagel 10x Genomics, Inc. (TXG) insider trading activity

John R Stuelpnagel is of 10x Genomics, Inc.. Currently has a direct ownership of 344,250 shares of TXG, which is worth approximately $5.2 Million. The most recent transaction as insider was on Jun 11, 2024, when has been sold 8,649 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 344K

0% 3M change

2.58% 12M change

Total Value Held $5.2 Million

JOHN R STUELPNAGEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2024	BUY Grant, award, or other acquisition	-	8,649 Added 2.45%	344,250 Class A Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	1,865 Added 0.55%	335,601 Class A Common Stock
Jun 05 2023	SELL Open market or private sale	$548,900 $54.89 p/Share	10,000 Reduced 2.91%	333,736 Class A Common Stock
Jun 15 2022	BUY Grant, award, or other acquisition	-	2,120 Added 0.61%	343,736 Class A Common Stock
Dec 30 2021	SELL Open market or private sale	$755,300 $151.06 p/Share	5,000 Reduced 1.44%	341,616 Class A Common Stock
Dec 01 2021	SELL Open market or private sale	$762,950 $152.59 p/Share	5,000 Reduced 1.42%	346,616 Class A Common Stock
Nov 16 2021	SELL Open market or private sale	$795,600 $159.12 p/Share	5,000 Reduced 1.4%	351,616 Class A Common Stock
Nov 01 2021	SELL Open market or private sale	$811,800 $162.36 p/Share	5,000 Reduced 1.38%	356,616 Class A Common Stock
Oct 18 2021	SELL Open market or private sale	$756,850 $151.37 p/Share	5,000 Reduced 1.36%	361,616 Class A Common Stock
Oct 07 2021	SELL Open market or private sale	$750,900 $150.18 p/Share	5,000 Reduced 1.35%	366,616 Class A Common Stock
Sep 16 2021	SELL Open market or private sale	$780,750 $156.15 p/Share	5,000 Reduced 1.33%	371,616 Class A Common Stock
Sep 01 2021	SELL Open market or private sale	$886,850 $177.37 p/Share	5,000 Reduced 1.31%	376,616 Class A Common Stock
Aug 16 2021	SELL Open market or private sale	$795,800 $159.16 p/Share	5,000 Reduced 1.29%	381,616 Class A Common Stock
Aug 02 2021	SELL Open market or private sale	$908,150 $181.63 p/Share	5,000 Reduced 1.28%	386,616 Class A Common Stock
Jul 16 2021	SELL Open market or private sale	$850,750 $170.15 p/Share	5,000 Reduced 1.26%	391,616 Class A Common Stock
Jul 01 2021	SELL Open market or private sale	$963,800 $192.76 p/Share	5,000 Reduced 1.24%	396,616 Class A Common Stock
Jun 17 2021	SELL Open market or private sale	$989,450 $197.89 p/Share	5,000 Reduced 1.23%	401,616 Class A Common Stock
Jun 11 2021	BUY Grant, award, or other acquisition	-	625 Added 0.15%	406,616 Class A Common Stock
Jun 01 2021	SELL Open market or private sale	$1,315,425 $175.39 p/Share	7,500 Reduced 1.81%	405,991 Class A Common Stock
May 17 2021	SELL Open market or private sale	$1,064,625 $141.95 p/Share	7,500 Reduced 1.78%	413,491 Class A Common Stock
May 03 2021	SELL Open market or private sale	$1,447,500 $193.0 p/Share	7,500 Reduced 1.75%	420,991 Class A Common Stock
Apr 16 2021	SELL Open market or private sale	$1,446,225 $192.83 p/Share	7,500 Reduced 1.72%	428,491 Class A Common Stock
Apr 01 2021	SELL Open market or private sale	$1,375,800 $183.44 p/Share	7,500 Reduced 1.69%	435,991 Class A Common Stock
Mar 17 2021	SELL Open market or private sale	$1,272,150 $169.62 p/Share	7,500 Reduced 1.66%	443,491 Class A Common Stock
Mar 01 2021	SELL Open market or private sale	$1,371,900 $182.92 p/Share	7,500 Reduced 1.64%	450,991 Class A Common Stock

JRS

John R Stuelpnagel

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account